WallStSmart
PLSM

Pulsenmore Ltd. Ordinary Shares

NASDAQ: PLSM · HEALTHCARE · MEDICAL DEVICES

$3.63
-4.82% today

Updated 2026-06-05

Market cap
$25.91M
P/E ratio
P/S ratio
1.86x
EPS (TTM)
$-0.85
Dividend yield
52W range
$3 – $2,226
Volume
0.0M

Pulsenmore Ltd. Ordinary Shares (PLSM) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$1.58M$10.59M$6.14M$9.64M$40.02M
Revenue growth (YoY)+571.7%-42.1%+57.1%+315.2%
Cost of revenue$242645.00$350212.00$1.37M$6.72M$6.10M$7.57M$6.34M
Gross profit$-242645.00$-350212.00$206844.00$3.87M$39657.00$2.07M$33.68M
Gross margin13.1%36.5%0.6%21.4%84.2%
R&D$2.74M$10.29M$10.61M$28.28M$30.07M$18.87M$17.35M
SG&A$8.90M$16.77M$19.01M$17.17M$5.52M
Operating income$-4.18M$-13.28M$-21.92M$-45.25M$-55.11M$-42.12M$-12.16M
Operating margin-1390.2%-427.2%-898.3%-437.0%-30.4%
EBITDA$-4.31M$-13.30M$-24.76M$-20.05M$-54.95M$-33.32M$-12.73M
EBITDA margin-1570.1%-189.3%-895.7%-345.7%-31.8%
EBIT$-4.56M$-13.65M$-25.32M$-21.32M$-57.34M$-36.17M$-15.54M
Interest expense$82287.00$95055.00$288782.00$341834.00$605781.00$538777.00$315000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.64M$-13.75M$-25.61M$-21.66M$-58.07M$-36.65M$-15.85M
Net income growth (YoY)-196.4%-86.3%+15.4%-168.0%+36.9%+56.7%
Profit margin-1623.9%-204.5%-946.5%-380.3%-39.6%

Frequently asked questions

How profitable is PLSM?

In its most recent fiscal year, PLSM ran a gross margin of 84.15%, an operating margin of -30.39%, and a net margin of -39.61%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PLSM generate?

PLSM produced $-33.01M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PLSM's balance sheet healthy?

PLSM holds $21.60M in cash and equivalents against — in long-term debt, on $83.09M of shareholder equity. That debt is best read against the cash flow the business throws off each year.